aztreonam 2000 MG Injection [Azactam]

Verify with CMS →

aztreonam

RxCUI: 1664988

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0%
Plan Coverage
2
Plans Covering
T1
Avg Tier
0%
Prior Auth Required

What the CMS Formulary Data Shows for aztreonam 2000 MG Injection [Azactam]

Per the CMS 2026 Part D formulary file, aztreonam 2000 MG Injection [Azactam] (RxNorm concept RXCUI 1664988, generic name aztreonam) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.

Real-world access to aztreonam 2000 MG Injection [Azactam] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,454 Part D beneficiaries filled aztreonam 2000 MG Injection [Azactam] in 2023, with total plan-and-beneficiary spending of $2,981,671 and an average per-beneficiary annual cost of $2,050.67. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry aztreonam 2000 MG Injection [Azactam] today.

Coverage Details

Formularies covering
1
Plans covering
2
Coverage rate
0%
Tier range
Tier 1, Preferred Generic
Average tier
Tier 1, Preferred Generic

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
1,454
Total spending
$2,981,671
Avg per beneficiary
$2,050.67

Tier Distribution Across Plans

2 plans
Tier 1, Preferred Generic

Medicare Advantage Plans (MA-PD) Covering aztreonam 2000 MG Injection [Azactam]

2 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
Hamaspik Medicare Choice (HMO D-SNP) HAMASPIK, INC. T1 No $0 NY
Hamaspik Medicare Select (HMO D-SNP) HAMASPIK, INC. T1 No $34.50 NY

Frequently Asked Questions

Is aztreonam 2000 MG Injection [Azactam] covered by Medicare Part D?

Yes, aztreonam 2000 MG Injection [Azactam] is covered by 2 Medicare Part D plans (0% of all Part D formularies).

What tier is aztreonam 2000 MG Injection [Azactam] on Medicare Part D plans?

aztreonam 2000 MG Injection [Azactam] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.

Does aztreonam 2000 MG Injection [Azactam] require prior authorization?

0% of Part D formularies require prior authorization for aztreonam 2000 MG Injection [Azactam]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on aztreonam 2000 MG Injection [Azactam]?

In 2023, total Medicare Part D spending on aztreonam 2000 MG Injection [Azactam] was $2,981,671, covering 1,454 beneficiaries. The average spend per beneficiary was $2,050.67.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial